Partnering with Eupraxia

Eupraxia’s technology platform, Diffusphere™, may be suitable for a wide range of indications and drugs that may be improved by locally targeted and extended release.

We welcome your enquiries. We are interested in flexibly collaborating with the global biomedical community in terms of potential in/out-licensing, strategic partnerships and research collaborations for both existing therapeutics as well as new chemical entities.

We are particularly interested in projects that advance our goals of efficiently and creatively meeting unmet medical needs and poorly addressed indications through meaningful, non-incremental advances in drug delivery, compartment kinetics, and advanced composite formulations.

Please direct your partnering enquiries to: